Drug Shortage Report for TEVA-COMBO STERINEBS
Report ID | 101702 |
Drug Identification Number | 02272695 |
Brand name | TEVA-COMBO STERINEBS |
Common or Proper name | IPRATROP SALB 0.5/2.5MG UDV |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | IPRATROPIUM BROMIDE SALBUTAMOL |
Strength(s) | 0.5MG 2.5MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION |
Packaging size | 20 x 2.5ml |
ATC code | R03AL |
ATC description | ADRENERGICS, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-12-18 |
Estimated end date | 2020-04-30 |
Actual end date | 2020-09-02 |
Shortage status | Resolved |
Updated date | 2020-09-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2020-09-03 | French | Compare |
v7 | 2020-09-03 | English | Compare |
v6 | 2020-03-26 | French | Compare |
v5 | 2020-03-26 | English | Compare |
v4 | 2020-01-09 | French | Compare |
v3 | 2020-01-09 | English | Compare |
v2 | 2019-12-19 | French | Compare |
v1 | 2019-12-19 | English | Compare |
Showing 1 to 8 of 8